Rachel L. Miller

Rachel L. Miller

Auto-generated profile, based on publicly available information

Rachel L. Miller

Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
RMRachel L. Miller
Rachel L. Miller
MGMitchell H. Grayson
Mitchell H. Grayson
KSKasey Strothman
Kasey Strothman

20 August 2019 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
O(on behalf of Breast Cancer and the Environment Research Program (BCERP)
on behalf of Breast Cancer and the Environment Research Program (BCERP)
MTMary Beth Beth Terry
Mary Beth Beth Terry
KMKarin B. Michels
Karin B. Michels
JBJulia Green Brody
Julia Green Brody
CBCelia Byrne
Celia Byrne
ATAmy Trentham-Dietz
Amy Trentham-Dietz
The long time from exposure to potentially harmful chemicals until breast cancer occurrence poses challenges for designing etiologic studies and for implementing successful prevention programs. Growing evidence from animal and human studies indicates that distinct time periods of heightened susceptibility to endocrine disruptors exist throughout the life course. The influence of environmental chemicals on breast cancer risk may be greater during several windows of susceptibility (WOS) in a woman’s life, including prenatal development, puberty, pregnancy, and the menopausal transition. These time windows are considered as specific periods of susceptibility for breast cancer because significant structural and functional changes occur in the mammary gland, as well as alterations in the mammary micro-environment and hormone signaling that may influence risk. Breast cancer research focused on these breast cancer WOS will accelerate understanding of disease etiology and prevention. Despite the plausible heightened mechanistic influences of environmental chemicals on breast cancer risk during time periods of change in the mammary gland’s structure and function, most human studies of environmental chemicals are not focused on specific WOS. This article reviews studies conducted over the past few decades that have specifically addressed the effect of environmental chemicals and metals on breast cancer risk during at least one of these WOS. In addition to summarizing the broader evidence-base specific to WOS, we include discussion of the NIH-funded Breast Cancer and the Environment Research Program (BCERP) which included population-based and basic science research focused on specific WOS to evaluate associations between breast cancer risk and particular classes of endocrine-disrupting chemicals—including polycyclic aromatic hydrocarbons, perfluorinated compounds, polybrominated diphenyl ethers, and phenols—and metals. We outline ways in which ongoing transdisciplinary BCERP projects incorporate animal research and human epidemiologic studies in close partnership with community organizations and communication scientists to identify research priorities and effectively translate evidence-based findings to the public and policy makers. An integrative model of breast cancer research is needed to determine the impact and mechanisms of action of endocrine disruptors at different WOS. By focusing on environmental chemical exposure during specific WOS, scientists and their community partners may identify when prevention efforts are likely to be most effective.

4 September 2015 in Current Environmental Health Reports
Verified
Journal Article
Closed access
PDF file
LRLacey Robinson
Lacey Robinson
RMRachel Miller
Rachel Miller

5 January 2018 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
MPMary Prunicki
Mary Prunicki
LSLaurel Stell
Laurel Stell
DDDeendayal Dinakarpandian
Deendayal Dinakarpandian
MPMariangels de Planell-Saguer
Mariangels de Planell-Saguer
RLRichard W. Lucas
Richard W. Lucas
Kari NadeauKari Nadeau
Kari Nadeau
DNA methylation of CpG sites on genetic loci has been linked to increased risk of asthma in children exposed to elevated ambient air pollutants (AAPs). Further identification of specific CpG sites and the pollutants that are associated with methylation of these CpG sites in immune cells could impact our understanding of asthma pathophysiology. In this study, we sought to identify some CpG sites in specific genes that could be associated with asthma regulation (Foxp3 and IL10) and to identify the different AAPs for which exposure prior to the blood draw is linked to methylation levels at these sites. We recruited subjects from Fresno, California, an area known for high levels of AAPs. Blood samples and responses to questionnaires were obtained (n = 188), and in a subset of subjects (n = 33), repeat samples were collected 2 years later. Average measures of AAPs were obtained for 1, 15, 30, 90, 180, and 365 days prior to each blood draw to estimate the short-term vs. long-term effects of the AAP exposures. Asthma was significantly associated with higher differentially methylated regions (DMRs) of the Foxp3 promoter region (p = 0.030) and the IL10 intronic region (p = 0.026). Additionally, at the 90-day time period (90 days prior to the blood draw), Foxp3 methylation was positively associated with NO2, CO, and PM2.5 exposures (p = 0.001, p = 0.001, and p = 0.012, respectively). In the subset of subjects retested 2 years later (n = 33), a positive association between AAP exposure and methylation was sustained. There was also a negative correlation between the average Foxp3 methylation of the promoter region and activated Treg levels (p = 0.039) and a positive correlation between the average IL10 methylation of region 3 of intron 4 and IL10 cytokine expression (p = 0.030). Short-term and long-term exposures to high levels of CO, NO2, and PM2.5 were associated with alterations in differentially methylated regions of Foxp3. IL10 methylation showed a similar trend. For any given individual, these changes tend to be sustained over time. In addition, asthma was associated with higher differentially methylated regions of Foxp3 and IL10.

1 November 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
RMRachel L. Miller
Rachel L. Miller
DPDavid B. Peden
David B. Peden

1 January 2018 in Environmental Research
Verified
Journal Article
Closed access
FPFrederica P. Perera
Frederica P. Perera
KWKylie Wheelock
Kylie Wheelock
YWYa Wang
Ya Wang
DTDeliang Tang
Deliang Tang
AMAmy E. Margolis
Amy E. Margolis
JHJulie B Herbstman
Julie B Herbstman